$35m payday for Neuren as blockbuster drug takes off
SYDNEY: Neuren Pharmaceuticals, the $1.5bn ASX-listed biotech company that for a few loyal investors has
SYDNEY: Neuren Pharmaceuticals, the $1.5bn ASX-listed biotech company that for a few loyal investors has
FEATURED
Brilliant breakthrough now set to assist MND sufferers
Affordable housing complex opens to aid seniors amid housing crisis
101-storey tower has been approved Boomer market
Government overrides planning niceties to fast track Regen site projects
Best social housing community design for Global Awards shortlisted
Developer rolls out affordable housing for seniors and low-income residents
INNOVATION
